The U.S. Food and Drug Administration today approved the first generic versions of Depakote delayed-release tablets (divalproex sodium). Depakote is approved by the FDA for the treatment of seizures, bipolar disorder and migraine headaches.
Source: http://www.news-medical.net/Pharmaceuticalnews.asp
Pharmaceutical News Feed